Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Ankara Universitesi Eczacilik Fakultesi Dergisi ; 46(2):194-211, 2022.
Article in Turkish | EMBASE | ID: covidwho-20233732

ABSTRACT

Objective: The aim of this study is to demonstrate the effects of Covid-19 pandemic to the pharmaceutical services in community pharmacies in Turkey. Material(s) and Method(s): This research is a descriptive study. In the study, a quantitative research questionnaire form prepared by the researchers was used. Questionnaires were delivered to the volunteers online. Participants were informed and participated in the study if they gave their consent with an informed consent form. Result and Discussion: It is understood that the community pharmacists in Turkey provide their pharmacy services with great devotion during the pandemic process, but they also cope with many problems. In particular, giving the masks free of charge through community pharmacies increased the workload of pharmacists and caused some disruptions in pharmacy services, in addition, the crowd of the citizens in pharmacies to buy masks increased the risk of social distancing and the possibility of transmission. Major problems faced by community pharmacists during the pandemic;Due to the high demand for personal protective equipment and hygiene materials, the increase in workload, the need for personnel, taking measures with their own means to protect against disease, not delivering drugs and products needed by the society on time, economic and / or social support, especially for the pharmacists have economic problems It is one of the important results of the study that the existence of a national emergency action plan will guide community pharmacists in combating this pandemic of unprecedented magnitudeCopyright © 2022 University of Ankara. All rights reserved.

2.
Int J Clin Pharm ; 2023 May 09.
Article in English | MEDLINE | ID: covidwho-2325330

ABSTRACT

BACKGROUND: When prescriptions are being processed in pharmacies, 'rework' is a phenomenon where an activity occurs that requires the return to a prior procedural step in the process for correction. To date, little is known regarding rework prevalence in community pharmacies or how this might be minimised. AIM: To evaluate the cause and frequency of prescription rework in community pharmacies. METHOD: A list of reworks was designed for community pharmacists to self-record prescription rework instances and causes in their workplace across a two-week period. Community pharmacists in Ireland were recruited via convenience sampling and snowballing. Descriptive statistics were used to assess rework frequency according to the various causes, as well as the pharmacist and pharmacy characteristics. RESULTS: Eight pharmacists participated, recording 325 reworks across 92.9% of the 65 study days (mean 5 reworks/day). The pharmacists' mean ranged from 1.82 to 15 reworks/day. Pharmacists and pharmacy technicians alone or together were involved in 72.3% of reworks. The three most common rework categories were involving labelling errors (22.8%), prepared prescriptions which necessitated opening and repackaging (15.1%), and medication owings to patients (13.9%). CONCLUSION: This study reveals that prescription rework occurs frequently in community pharmacies and has provided an indication of some of the main causes. These findings demonstrate areas where pharmacy staff can address rework and should aid the development of approaches to minimise rework in future - thus decreasing workload and facilitating more time for community pharmacy staff to focus on providing patient care.

3.
Explor Res Clin Soc Pharm ; 10: 100261, 2023 Jun.
Article in English | MEDLINE | ID: covidwho-2303099

ABSTRACT

Introduction: Pharmacists and community pharmacies play an important role in managing, identifying and preventing the spread of the COVID-19 outbreak. Objectives: To characterize the global panorama of action by pharmacists and community pharmacies in facing the COVID-19 pandemic. Methods: The scoping review was based on the search for scientific articles in the databases: PubMed; Scopus; ScienceDirect and Web of Science. The search was carried out on August 31, 2021. The selection process was divided into 3 phases: i) title analysis; ii) analysis of study abstracts; iii) analysis of the full texts of the studies selected in the previous step. Studies were independently selected by two investigators and discrepancies resolved by consensus during focus group discussions led by a third reviewer. Results: The final search yielded 36 articles for the review. The main strategies for coping with COVID-19 were grouped into 4 categories defined by consensus between the authors: (1) services for providing care to the patient; (2) product management; (3) infection prevention and control practices in community pharmacy; (4) preparation, sources of information used and training offered/received. Through these, the aim was to involve technical managerial, technical assistance and pedagogical technical actions adopted, as well as structure and process indicators that allowed the continuity of the offer of services. Conclusion: During the pandemic, pharmacists and community pharmacies have been providing essential health services to communities. The results of this review may help to identify the changes adopted to face the COVID-19 pandemic and may contribute to improving the quality of practices in these establishments during the pandemic and after it, in similar situations.

4.
International Journal of Pharmaceutical Sciences Review and Research ; 78(1):94-100, 2023.
Article in English | EMBASE | ID: covidwho-2277415

ABSTRACT

Introduction: The main prevention of cardiovascular disease (CVD) and healthcare cost reduction depend on the early identification and treatment of cardiovascular disease (CVD) risk factors through screening. Hypertension, obesity, a large waist circumference, smoking, poor diets, physical inactivity, and excessive alcohol consumption are well-known and potentially treatable risk factors for cardiovascular disease. This allows for early detection of instances, informs the start of CVD prevention medication, and is also very cost-effective. Method(s): At rural India, between March and August 2021, a cross-sectional survey was conducted in community pharmacies. One thousand two hundred healthy individuals were screened for signs of obesity, high blood pressure, waist circumference, and history of smoking and alcohol intake. A structured questionnaire was used to get participants' physical activity and diet. Result(s): The gender split of the 1200 participants who were screened was 67.8% male and 32.3% female. Participants' ages ranged from 18 to 60 years old in 43.3% of cases, 41 to 60 years old in 26.3%, and over 60 in 30.4% of cases. There were 43.7% of drinkers and 47.3% of smokers, respectively. A BMI of 25 kg/m2 or more indicates being overweight, whereas a BMI of 30 kg/m2 indicates being obese. Using a diagnostic cutoff of >140/90mmHg prevalence of hypertension was 44.3%, and 14.9% out of these were previously hypertensive. 31.5% had high waist circumference, 13.9% had insufficient physical activity, and 34.9% had insufficient intake of fruits and vegetables. Conclusion(s): The majority felt that screening for CVD risk factors was helpful, and more than one-fourth of the study participants had two or more CVD risk factors combined. A cost-effective strategy for the primary prevention of CVD that can have a positive influence on the healthcare delivery system is the capacity to further discover previously undetected risk factors.Copyright © 2023, Global Research Online. All rights reserved.

5.
Ankara Universitesi Eczacilik Fakultesi Dergisi ; 46(2):194-211, 2022.
Article in Turkish | EMBASE | ID: covidwho-2253546

ABSTRACT

Objective: The aim of this study is to demonstrate the effects of Covid-19 pandemic to the pharmaceutical services in community pharmacies in Turkey. Material(s) and Method(s): This research is a descriptive study. In the study, a quantitative research questionnaire form prepared by the researchers was used. Questionnaires were delivered to the volunteers online. Participants were informed and participated in the study if they gave their consent with an informed consent form. Result and Discussion: It is understood that the community pharmacists in Turkey provide their pharmacy services with great devotion during the pandemic process, but they also cope with many problems. In particular, giving the masks free of charge through community pharmacies increased the workload of pharmacists and caused some disruptions in pharmacy services, in addition, the crowd of the citizens in pharmacies to buy masks increased the risk of social distancing and the possibility of transmission. Major problems faced by community pharmacists during the pandemic;Due to the high demand for personal protective equipment and hygiene materials, the increase in workload, the need for personnel, taking measures with their own means to protect against disease, not delivering drugs and products needed by the society on time, economic and / or social support, especially for the pharmacists have economic problems It is one of the important results of the study that the existence of a national emergency action plan will guide community pharmacists in combating this pandemic of unprecedented magnitudeCopyright © 2022 University of Ankara. All rights reserved.

6.
Ankara Universitesi Eczacilik Fakultesi Dergisi ; 46(2):194-211, 2022.
Article in Turkish | EMBASE | ID: covidwho-2253545

ABSTRACT

Objective: The aim of this study is to demonstrate the effects of Covid-19 pandemic to the pharmaceutical services in community pharmacies in Turkey. Material(s) and Method(s): This research is a descriptive study. In the study, a quantitative research questionnaire form prepared by the researchers was used. Questionnaires were delivered to the volunteers online. Participants were informed and participated in the study if they gave their consent with an informed consent form. Result and Discussion: It is understood that the community pharmacists in Turkey provide their pharmacy services with great devotion during the pandemic process, but they also cope with many problems. In particular, giving the masks free of charge through community pharmacies increased the workload of pharmacists and caused some disruptions in pharmacy services, in addition, the crowd of the citizens in pharmacies to buy masks increased the risk of social distancing and the possibility of transmission. Major problems faced by community pharmacists during the pandemic;Due to the high demand for personal protective equipment and hygiene materials, the increase in workload, the need for personnel, taking measures with their own means to protect against disease, not delivering drugs and products needed by the society on time, economic and / or social support, especially for the pharmacists have economic problems It is one of the important results of the study that the existence of a national emergency action plan will guide community pharmacists in combating this pandemic of unprecedented magnitudeCopyright © 2022 University of Ankara. All rights reserved.

7.
Explor Res Clin Soc Pharm ; 9: 100239, 2023 Mar.
Article in English | MEDLINE | ID: covidwho-2260441

ABSTRACT

Background: Reports of increased stress among healthcare workers were commonplace during the early days of the COVID-19 pandemic, but little is known about community pharmacists' experiences. Objective: To characterize community pharmacists' stress and confidence during the early COVID-19 pandemic and identify associated factors. Methods: Pharmacists who worked in a brick-and-mortar community pharmacy (e.g., big-box, chain, independent, or grocery pharmacies) located in Connecticut and had regular face-to-face interaction with the public were surveyed. Survey items were selected from the Perceived Stress Scale-10 (PSS-10) and adapted from the Emergency Risk-Communication (ERC) framework. Data were analyzed using chi-square and ANOVA. Results: Survey results suggested pharmacists experienced moderate levels of stress, as negative responses to PSS-10 items ranged between 6.4% to 43.3%, respectively. Overall, pharmacists had high rates of confidence in their ability to manage the pandemic, agreeing or strongly agreeing that they could manage their own mental health (73.1%), and communicate the risks of the pandemic (72.0%). However, 28.0% reported that they had avoided talking about the pandemic because it made them feel "stressed, or nervous." Women and those working in chain community pharmacies tended to report significantly higher rates of stress to several items in the PSS-10 compared to men and pharmacists working in non-chain settings. Women and chain community pharmacists were also significantly more likely to report overall that they had avoided talking about public health risks because it made them feel anxious, stressed, or depressed (29.4% men vs. 34.5% women χ2 (4) > 22.6, p < 0.01). However, confidence to communicate critical risk messages neither differed between men and women (77.6% men vs. 68.8% women χ2 (4) > 8.3, p = 0.08), nor between chain and non-chain community pharmacists (71.0% chain vs. 73.7% non-chain χ2 (4) > 8.9, p = 0.32). Conclusion: Being female, younger age, and employed at a chain pharmacy were associated with higher rates of stress and lower self-confidence among community pharmacists during the COVID-19 pandemic.

8.
Int J Environ Res Public Health ; 20(5)2023 02 21.
Article in English | MEDLINE | ID: covidwho-2251218

ABSTRACT

Thanks to their distribution throughout the territory and extended opening hours, community pharmacists are among the healthcare specialists most easily accessible to the public and often represent the first point of consultation both for the treatment of acute health conditions and, more generally, for health and therapy advice. The objective of the present study was to evaluate whether post-graduate courses/further training courses for pharmacists might influence the quality of patient management and care and, consequently, the satisfaction of the users who entered the pharmacy. We used the revenues of the pharmacies (Group A) in which these pharmacists are employed as a performance indicator. We compared the data for this group with the national averages for Italian pharmacies (Group B) and with those of a group (Group C) of selected pharmacies as similar as possible to the pharmacies in Group A based on a number of well-defined parameters. The comparison of revenues, year-on-year changes, and the average number of sales by the pharmacies in the three groups indicates that the pharmacies in Group A had the best performance, not only when compared with the national average but especially compared with the control group, specifically selected to make the comparison as significant as possible.


Subject(s)
COVID-19 , Community Pharmacy Services , Pharmacies , Humans , SARS-CoV-2 , Pandemics , Pharmacists , Patient Care
9.
Innov Pharm ; 13(3)2022.
Article in English | MEDLINE | ID: covidwho-2205361

ABSTRACT

The coronavirus disease 2019 (COVID-19) has altered the healthcare landscape for pharmacy practice and continues its global onslaught. As the COVID-19 vaccines began to reach the general population, many were left wondering where and when they would get the vaccine. With 90% of the American population living within 5 miles of a community pharmacy, vaccine distribution to these locations is vital for a successful vaccine campaign. The Biden Administration launched the Federal Retail Pharmacy Program (FRPP) in February 2021, a public-private partnership with 21 national pharmacy partners representing over 40,000 pharmacy locations to help expand the vaccine rollout. Community pharmacists are uniquely positioned to fulfill this mission by being a point of contact for the COVID-19 vaccination efforts. The FRPP has experienced some limitations, including the variable vaccine allocation, limited support from the healthcare system, and the lack of overwhelming public confidence in the vaccines. Improving the FRPP would require strong partnership with other healthcare professionals and the adoption of flexible vaccine dissemination. These can stem future pandemics.

10.
Vaccines (Basel) ; 10(12)2022 Dec 14.
Article in English | MEDLINE | ID: covidwho-2163718

ABSTRACT

Influenza surveillance and influenza vaccination are the key activities for preventing and controlling influenza epidemics. The study assessed the influenza surveillance and influenza vaccination data obtained from sentinel pharmacies of Catalonia, Spain, in the 2021-2022 influenza season. The sentinel pharmacies were selected from all community pharmacies to report all influenza-like illness (ILI) cases detected during the 2021-2022 influenza season and collect influenza surveillance and influenza vaccination data. The ILI cases were identified based on European Centre for Disease Control (ECDC) criteria. The moving epidemic method (MEM) was used to assess the ILI epidemic activity. The screening method was used to assess influenza vaccination effectiveness in patients aged 65-or-more years old. The sentinel pharmacies reported 212 ILI cases with a negative COVID-19 test and a total number of 412 ILI cases. An absence of increased ILI epidemic activity was observed in the 2021-2022 influenza season based on two criteria: (1) Number of ILI cases reported per week in the 2021-2022 influenza season significantly lower than the MEM-based epidemic threshold. (2) Mean number of ILI cases reported per week in the 2021-2022 influenza season significantly lower than during the ILI/influenza epidemic periods detected from 2017 to 2020 using the same methodology. Influenza vaccination was effective in preventing ILI among patients aged 65-or-more-years old. The absence of the influenza epidemic during the 2021-2022 influenza season could be explained by influenza vaccination and COVID-19 prevention measures (wearing face masks, social distancing). The sentinel pharmacies provided influenza surveillance data not provided by traditional influenza surveillance systems.

11.
Front Pharmacol ; 13: 916223, 2022.
Article in English | MEDLINE | ID: covidwho-2142193

ABSTRACT

Background: There has been an appreciable increase in the use of herbal supplements, including immune boosters, during the current COVID-19 pandemic. However, there are concerns with falsified herbal supplements. Objectives: Developed a new questionnaire that can potentially help community pharmacists identify the extent of falsified herbal supplements. Methods: A 9-month cross sectional study was conducted among 500 community pharmacies across United Arab Emirates. A new 5-factor, 24-itmes scale was developed based on current labelling requirements across countries and piloted. This included seven items on identified uses and contraindication, seven items on hazard identification, four items on product identity, three items on packaging and product insert and three items on product handling and storage. The face and content validity of the scale was assessed via the content validity index (CVI). Its construct validity was tested using an exploratory factor analysis (EFA) via principally component analysis (PCA). The model was subsequently confirmed through partial confirmatory factor analysis (PCFA). Its reliability was assessed via test-retest reliability, internal consistency, item internal consistency (IIC), and intraclass correlation coefficients (ICCs). Results: The CVI of the finalized questionnaire was 0.843. The Kaiser-Meyer-Olkin measure of sampling adequacy was 0.891, and Bartlett's test of sphericity indicated significance (p-value < 0.001). Confirmation of the subsequent 5-domains was achieved through PCFA using maximum likelihood analysis with oblimin rotation. The PCFA obtained values was 0.962 for NFI, 0.977 for CFI, and 0.987 for the Tucker Lewis Index. All values were greater than 0.95, and the RMSEA value was 0.03 (i.e., less than 0.06). Consequently, the model had a good fit. All domains demonstrated Cronbach's alpha coefficients above 0.70, with 0.940 for the full instrument. Meanwhile, all items met the IIC correlation standard of ≥0.40. The instrument presented good ICC statistics of 0.940 (0.928-0.950) as well as statistical significance (p < 0.001). Community pharmacists with more than 10 experience years were more likely to identify falsified herbal supplements compared to those with 1-10 years experience (p < 0.001). Conclusion: This study developed and validated a new instrument to identify safe herbal supplements, which should enhance the role of the community pharmacists in the safe and effective treatment of suitable patients with herbal supplements.

12.
J Pharm Policy Pract ; 15(1): 76, 2022 Oct 29.
Article in English | MEDLINE | ID: covidwho-2098464

ABSTRACT

OBJECTIVE: To assess public opinion about community pharmacy services in Lebanon during the COVID-19 pandemic. METHOD: A cross-sectional study using an online questionnaire was conducted between April and August of 2021. A link was shared randomly among the Lebanese population using WhatsApp and Facebook. Public perceptions were explored within 3 different indicators: general services (B) dispensing (C), and storage (D). Chi-square, Student's test and ANOVA tests were used. p < 0.05 was considered statistically significant. RESULTS: Out of 491 responses, only 9.6% scored above the 75th percentile (19.3% for the general services, 2.4% for dispensing indicator and 12.6% for storage indicator). The main concerns focused on lack of medication and reduced opening hours; however, 67.1% of respondents preferred consulting the community pharmacist instead of visiting primary health care centers, doctor's private clinic and hospitals. Higher mean values of indicators B, C and in the overall indicator were significantly found in the presence of a pharmacist compared to the support pharmacy workforce. CONCLUSION: The overall public perception was inadequate. Significant difference in terms of quality of services was detected in the presence and absence of a community pharmacist during the crisis. It is recommended that the Order of Pharmacist of Lebanon (OPL) and the Ministry of Public Health (MOPH) undergo further steps mainly to enforce the laws concerning dispensing and storage indicators, improve the services in terms of extending the opening hours, ensure the availability of medicines and increase public awareness.

13.
Malays J Med Sci ; 29(4): 160-164, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-2026173

ABSTRACT

Depression is the most common condition affecting the mental health of individuals. During the whole lifetime, at least one in four individuals go through an episode of this disorder. Recently, the Malaysian number of cases has increased to around 500,000 with more adding due to COVID-19 pandemic. The first professionals to detect depression by analysing the rather emotional, presenting symptoms of the patient are the family physicians. In such circumstances, how is it possible for a community pharmacist to identify undiagnosed depression? Depression is real, sadly, the silent nature of the disorder results in an increase in its unreported cases. On the bright side we believe the new screening guidelines and intervention of community pharmacists might be one noble way to aid in the opportunistic risk screening of depression and heal the hidden emotions during COVID-19.

14.
ARCHIVES OF PHARMACY PRACTICE ; 13(2):62-65, 2022.
Article in English | Web of Science | ID: covidwho-1939778

ABSTRACT

The involvement of pharmacists and pharmacies in the vaccination campaign represents an important opportunity to confirm the professional role played and the function of a local health unit. The pharmacy is one of the points of contact and interaction most frequented by the population;it is widespread throughout the national territory, and thanks to its professionals, it plays and can play, even more, an essential role in the networks for the prevention and protection of the health of our communities. The SARS-CoV-2 pandemic has highlighted the necessity for close collaboration and integration between health professionals to ensure an influential response. The pandemic also made it clear how prevention is an essential component of our health and social systems and how this must find, alongside a precise and stronger organizational dimension, also a concrete and operational declination in the various aspects of our daily life and certainly in the moments contact with the various health services. In this work, through an analysis of the scientific literature, we aim to identify and describe the advantages that can derive from the involvement of community pharmacists in prevention networks.

15.
Antibiotics (Basel) ; 11(5)2022 Apr 27.
Article in English | MEDLINE | ID: covidwho-1809660

ABSTRACT

COVID-19 has had a significant impact on health care systems, including drug use. The present study aimed to evaluate the patterns of community supply of antimicrobials from community pharmacies during the COVID-19 pandemic in five cities of Russia. In a cross-sectional study, a random sample of pharmacies reported all episodes of antimicrobials supply during a one-week period. Patterns of supply (age and gender of customer, drug name and formulation, prescription availability, indication, etc.) were analyzed. Altogether, 71 pharmacies took part in the study and 5270 encounters were recorded. In total, 4.2% of visits resulted in supply of more than one antimicrobial agent and 5.2% were for parenteral formulations. The rate of prescription-based purchase in participated cities varied from 40.5 to 99.1%. Systemic antibiotics and antivirals accounted for the majority of supplies (60.5 and 26.3%, respectively). Upper respiratory tract infections were reported as the indication for antimicrobials usage in 36.9% of cases, followed by skin and soft tissue infections (12.1%) and urinary tract infections (8.7%); COVID-19 accounted for 8.4% of all supplies. Amoxicillin with clavulanic acid, azithromycin and amoxicillin were indicated as the top three antimicrobials purchased for upper respiratory tract infections, and azithromycin, umifenovir and levofloxacin were the top three for COVID-19. In general, a high rate of drugs dispensing without prescription was revealed. Antibiotics for systemic use remained the most common antimicrobials, whereas presumably viral upper respiratory tract infections were the main reason for their purchase. COVID-19 infection itself was responsible for a small proportion of the supply of antimicrobial agents, but systemic antibiotics accounted for more than a half of supplies.

16.
Value Health ; 25(8): 1321-1327, 2022 08.
Article in English | MEDLINE | ID: covidwho-1783607

ABSTRACT

OBJECTIVES: In Portugal, the dispensing of most outpatient specialty medicines is performed exclusively through hospital pharmacies and totally financed by the National Health Service. During the COVID-19 first wave, the government allowed the transfer of the dispensing of hospital-only medicines (HOMs) to community pharmacies (CPs). This study aimed to measure the value generated by the intervention of CP in the dispensing of HOM. METHODS: A single-arm, before-and-after study with 3-month follow-up was conducted enrolling a randomly selected sample of patients or caregivers with at least 1 dispensation of HOM through CP. Data were collected by telephone interview. Main outcomes were patients' self-reported adherence (Measure Treatment Adherence), health-related quality of life (EQ-5D 3-Level), satisfaction with the service, and costs related to HOM access. RESULTS: Overall 603 subjects were recruited to participate in the study (males 50.6%) with mean 55 years old (SD = 16). The already high mean adherence score to therapy improved significantly (P < .0001), and no statistically significant change (P > .5757) was found in the mean EQ-5D score between baseline (0.7 ± 0.3) and 3-month follow-up (0.8 ± 0.3). Annual savings account for €262.1/person, arising from travel expenses and absenteeism reduction. Participants reported a significant increase in satisfaction levels in all evaluated domains-pharmacist's availability, opening hours, waiting time, privacy conditions, and overall experience. CONCLUSIONS: Changing the dispense setting to CP may promote better access and satisfaction. Moreover, it ensures the persistence of treatments, promotes savings for citizens, and reduces the burden of healthcare services, representing a crucial public health measure.


Subject(s)
COVID-19 Drug Treatment , COVID-19 , Community Pharmacy Services , Pharmacies , COVID-19/epidemiology , Female , Hospitals , Humans , Male , Middle Aged , Pandemics , Quality of Life , State Medicine
17.
Int J Pharm Pract ; 30(3): 226-234, 2022 Jun 25.
Article in English | MEDLINE | ID: covidwho-1769291

ABSTRACT

BACKGROUND: Community pharmacies provide an important healthcare service. Their significant value has been further highlighted during the COVID-19 pandemic crisis. OBJECTIVES: To identify and categorize potential barriers and facilitators to the role of community pharmacists during the pandemic and their association with demographic factors. METHODS: A cross-sectional survey of community pharmacists was conducted using a self-administered questionnaire during April 2020 across all regions of Egypt. KEY FINDINGS: Respondents (n = 1018; 98.4% response rate) revealed practical and psychological barriers, including inadequate levels of pandemic preparedness (mean 61.43%; ±SD 0.47), inadequate working environments (mean 56.23%; ±SD 0.49) and uncooperative behaviour from stakeholders (mean 65.3%; ±SD 0.47).The majority of respondents emphasized the universal, region-independent necessity for facilitators, including the availability of timely (94.9%) guidance (97.4%) published by the Egyptian healthcare authority (94.6%), in electronic format (82.1%), through smartphone application (80.0%) and the provision of a dedicated telephone hotline (89.5%). Furthermore, authorities must use the media to manage public perceptions (97.2%) and increase public trust (94.8%) towards the pharmacist. CONCLUSIONS: The barriers and facilitators identified herein could improve service provision in an integrated manner by overcoming the reported inadequate level of preparedness (barrier) through the provision of electronic guidance (facilitator), and the use of the media in managing public perceptions and trust (facilitators) to reduce the panic that negatively affects the working environment (barrier) for pharmacy staff. The varied level of healthcare authority cooperation reported in many regions requires further investigation.


Subject(s)
COVID-19 , Community Pharmacy Services , Pharmacies , Pharmacy , Cross-Sectional Studies , Humans , Pandemics , Pharmacists/psychology , Professional Role
18.
Latin American Journal of Pharmacy ; 41(1):261-265, 2022.
Article in English | Web of Science | ID: covidwho-1663076

ABSTRACT

Globally, pharmacists were reported to help in medication supply and delivery, increase public's awareness about the disease, help in testing for COVID-19 and recently administer the vaccine. This study aims to assess the perspective of pharmacists toward providing COVID-19 vaccination at community pharmacies. Self-administered survey was developed and distributed to 252 community pharmacists in the Aseer region, Saudi Arabia. Statistical analysis was conducted using SPSS software, version 21. The response rate was 78% where 196 community pharmacists have completed and returned the questionnaire. The majority of participants were males (84%), age between 20-30 years (60.7%), and working at chain pharmacies (86.2%). More than 60% of the participants agree that community pharmacists should be involved in the COVID-19 vaccination, and they would help to speed-up the vaccination process among the public. Most of the participants (72.9%) agree that participation of community pharmacists would ease the stress on ministry of health vaccination centers. The main two barriers that may face the community pharmacists are lack of privacy at the pharmacy and lack of time to provide the vaccination (54.1% and 62.8% respectively). In conclusion, community pharmacists are capable of providing vaccination services and help gaining mass immunity sooner.

19.
Rural Remote Health ; 21(3): 6630, 2021 07.
Article in English | MEDLINE | ID: covidwho-1478860

ABSTRACT

INTRODUCTION: On 15 June 2020, the National Public Health Organization was informed about the identification of two cases of Escherichia coli Ο157 infection in a small town in the Peloponnese Region in Greece and we suspected an outbreak. METHODS: We asked the local pharmacist to assist us to verify the outbreak by providing the daily number of over-the-counter anti-diarrheal drugs sold from 20 May 2020 onwards. The pharmacist asked customers with gastroenteritis to submit stool samples at the local hospital. Samples were tested for 22 pathogens. We conducted a 1 : 1 case-control study. Cases and controls were retrieved from the pharmacy client list. Chlorination records of the water supply system were retrieved, and water samples were tested for microbiological indicators and viruses. RESULTS: The increased number of sales of anti-diarrheal drugs verified the outbreak. Overall, 58 cases and 57 controls were recruited for the study. Tap water consumption (odds ratio (OR)=10.9, 95% confidence interval (CI)=3.1-38.0, p<0.001) and consumption of ice cubes made from tap water (OR=39.3, 95%CI=10.3-150.9, p<0.001) were independently associated with gastroenteritis occurrence. Eleven stool samples were tested; one was positive for shigatoxin-producing E. coli, one for enteropathogenic E. coli, four for E. coli Ο157 and one for Salmonella spp. Four samples tested negative. Five water samples collected on 18 June tested negative. The residual chlorine on 5 and 14 June ranged from 0.12 mg/L to 0.14 mg/L. CONCLUSION: This was the first investigation of a waterborne outbreak in Greece performed with the collaboration of a local pharmacy. The COVID-19 pandemic favored the use of alternative resources and channels of communication with the local population, which can also be used in the future, especially in remote areas of the country.


Subject(s)
COVID-19 , Diarrhea/epidemiology , Disease Outbreaks , Escherichia coli/isolation & purification , Water Supply , Waterborne Diseases/epidemiology , Adult , Case-Control Studies , Female , Greece/epidemiology , Humans , Male , Middle Aged , Pandemics , Rural Population , SARS-CoV-2 , Waterborne Diseases/physiopathology
20.
Int J Environ Res Public Health ; 18(18)2021 Sep 11.
Article in English | MEDLINE | ID: covidwho-1409511

ABSTRACT

Community pharmacies are among the most easily accessible health services. Considering the major impact of COVID-19 in social terms, the purpose was to analyse the evolution of the relationship between community pharmacies and customers during the pandemic in 2020 and to understand which strategies should be implemented in the future. The data have been collected from May to December 2020. Pharmacists administered a questionnaire, also available online, to all customers that agreed to participate. The total number of respondents was 502. The results obtained confirm a generally high level of satisfaction with pharmacies among customers and appreciation for the role of community pharmacies. For the future, the priority is to monitor the situation to break down social inequalities. A task that can be entrusted to the branch of the healthcare service ideally suited to this end: local medicine, of which the community pharmacy is an essential element. The post-pandemic pharmacy will need to have the skills to provide accurate and reliable information on issues, including broad topics such as prevention and lifestyle to fight "syndemic" (two or more factors that work together to make a disease worse) and "infodemic" (too much information including false or misleading information during a disease outbreak).


Subject(s)
COVID-19 , Community Pharmacy Services , Pharmacies , Humans , Italy/epidemiology , Pandemics , Pharmacists , Professional Role , SARS-CoV-2 , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL